NEWS
New Feature!!!! University Subject Rankings in 12 branches
FOR SCIENTIST REGISTRATION FOR INSTITUTIONAL BULK REGISTRATION
FOR EDIT YOUR UNIVERSITY / INSTITUTION PAGE
Some differences of the AD Scientific Index
New Feature!!!! University Subject Rankings in 12 branches
List without CERN, Statistical Data etc. Only in AD Scientific Index
New Feature!!!! University Subject Rankings in 12 branches
AD
Scientific Index 2024
About Us
Methodology
Compare & Choose
Contact - FAQ
login
Login
person_add
Register
school
University Rankings
subject
University Subject Rankings
place
Country Rankings
insights
i10 Productivity Rankings
insights
Subject Rankings
format_list_numbered
Top 100 Scientists
format_list_numbered
Citation Rankings
format_quote
Top 100 Institutions
local_fire_department
Country Top Lists
Arup R Chakraborty
AD Scientific Index 2024
Natural Sciences / Molecular Biology & Genetics
National Institutes of Health - Bethesda, Maryland / United States
Edit Form
Registration, Add Profile,
Premium Membership
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Arup R Chakraborty's MOST POPULAR ARTICLES
1-)
Association of MGMT Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide: An Analysis From the NRG …JAMA Oncology, 20181312018
2-)
Histone deacetylase inhibitors: emerging mechanisms of resistanceRW Robey, AR Chakraborty, A Basseville, V Luchenko, J Bahr, Z Zhan, ...Molecular pharmaceutics 8 (6), 2021-2031, 20111272011
3-)
SMARCA4/BRG1 is a novel prognostic biomarker predictive of cisplatin-based chemotherapy outcomes in resected non-small cell lung cancerAC Erica Hlavin Bell1,*, Arup R Chakraborty1, Xiaokui Mo2, Ziyan Liu1 ...Clinical Cancer Research, 201598*2015
4-)
MAPK pathway activation leads to Bim loss and histone deacetylase inhibitor resistance: rationale to combine romidepsin with an MEK inhibitorAR Chakraborty, RW Robey, VL Luchenko, Z Zhan, RL Piekarz, JP Gillet, ...Blood, The Journal of the American Society of Hematology 121 (20), 4115-4125, 2013892013
5-)
Circulating microRNAs in cancer: Hope or hype?CA Singh R1, Ramasubramanian B1, Kanji S1, Chakraborty AR1, Haque SJ1Cancer Letters, 2016822016
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept